NYSE:SOLV - US83444M1018 - Common Stock
The current stock price of SOLV is 73.55 USD. In the past month the price decreased by -1.61%. In the past year, price increased by 19.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 27.34 | 40.99B | ||
COO | COOPER COS INC/THE | 19.39 | 15.01B | ||
ALGN | ALIGN TECHNOLOGY INC | 15.89 | 10.84B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 24.44 | 5.30B | ||
BLCO | BAUSCH + LOMB CORP | 35.57 | 5.29B | ||
LNTH | LANTHEUS HOLDINGS INC | 9.11 | 3.96B | ||
ICUI | ICU MEDICAL INC | 17.05 | 3.16B | ||
XRAY | DENTSPLY SIRONA INC | 8.57 | 2.92B | ||
HAE | HAEMONETICS CORP/MASS | 12.12 | 2.72B | ||
UFPT | UFP TECHNOLOGIES INC | 26.16 | 1.74B | ||
STAA | STAAR SURGICAL CO | N/A | 1.37B | ||
ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.26B |
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The firm's segments include MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. MedSurg segment provides solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, and others. Dental Solutions segment provides a suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. Health Information Systems segment provides healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, and data visualization platforms. Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 22000
Phone: 16517331110
The current stock price of SOLV is 73.55 USD. The price increased by 2.15% in the last trading session.
The exchange symbol of SOLVENTUM CORP is SOLV and it is listed on the New York Stock Exchange, Inc. exchange.
SOLV stock is listed on the New York Stock Exchange, Inc. exchange.
19 analysts have analysed SOLV and the average price target is 88.5 USD. This implies a price increase of 20.33% is expected in the next year compared to the current price of 73.55. Check the SOLVENTUM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SOLVENTUM CORP (SOLV) has a market capitalization of 12.75B USD. This makes SOLV a Large Cap stock.
SOLVENTUM CORP (SOLV) currently has 22000 employees.
SOLVENTUM CORP (SOLV) has a support level at 73.35 and a resistance level at 73.76. Check the full technical report for a detailed analysis of SOLV support and resistance levels.
The Revenue of SOLVENTUM CORP (SOLV) is expected to grow by 3.27% in the next year. Check the estimates tab for more information on the SOLV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SOLV does not pay a dividend.
SOLVENTUM CORP (SOLV) will report earnings on 2025-11-03.
The PE ratio for SOLVENTUM CORP (SOLV) is 12.1. This is based on the reported non-GAAP earnings per share of 6.08 and the current share price of 73.55 USD. Check the full fundamental report for a full analysis of the valuation metrics for SOLV.
The outstanding short interest for SOLVENTUM CORP (SOLV) is 2.72% of its float. Check the ownership tab for more information on the SOLV short interest.
ChartMill assigns a technical rating of 2 / 10 to SOLV. When comparing the yearly performance of all stocks, SOLV turns out to be only a medium performer in the overall market: it outperformed 67.89% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SOLV. There are concerns on the financial health of SOLV while its profitability can be described as average.
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 6.08. The EPS decreased by -64.49% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.53% | ||
ROA | 2.52% | ||
ROE | 10.43% | ||
Debt/Equity | 2.14 |
19 analysts have analysed SOLV and the average price target is 88.5 USD. This implies a price increase of 20.33% is expected in the next year compared to the current price of 73.55.
For the next year, analysts expect an EPS growth of -10.29% and a revenue growth 3.27% for SOLV